首页> 外文期刊>The Open Ophthalmology Journal >Weighing in Ocular Perfusion Pressure in Managing Glaucoma
【24h】

Weighing in Ocular Perfusion Pressure in Managing Glaucoma

机译:青光眼治疗中眼压的权衡

获取原文
       

摘要

The role of vascular risk factors in glaucoma is increasingly being supported by the literature, with the association between low ocular perfusion pressure (PP) and glaucoma being the most consistent result. However, we need to be cautious when interpreting these results and consider all possible confounders in the observed associations. While we assess PP through its principal components, the weight of intraocular pressure (IOP) and blood pressure (BP) in the PP equation remains unknown. Also, the role of PP in glaucoma needs to be elucidated with regards to IOP and BP fluctuation during the 24hour period and the effect of IOP-lowering and BP-lowering treatment. The complexity of the interaction of PP with other potential risk factors for glaucoma means that PP cannot be currently considered in the assessment of an individual patient. The role of PP in glaucoma warrants further research and randomized clinical trials assessing PP should include vision and/or structure preservation as end-points and ideally address all of the above issues.
机译:文献中越来越多地支持了血管危险因素在青光眼中的作用,其中最一致的结果是低眼压(PP)与青光眼之间的关系。但是,在解释这些结果时,我们需要谨慎,并在观察到的关联中考虑所有可能的混杂因素。虽然我们通过PP的主要成分对其进行评估,但PP方程中的眼内压(IOP)和血压(BP)的权重仍然未知。此外,关于24小时内眼压和血压波动以及降低眼压和降低血压的效果,还需要阐明PP在青光眼中的作用。 PP与青光眼其他潜在危险因素相互作用的复杂性意味着,目前在单个患者评估中不能考虑使用PP。 PP在青光眼中的作用值得进一步研究,评估PP的随机临床试验应将视力和/或结构保存作为终点,并理想地解决所有上述问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号